05:51 PM EDT, 08/14/2025 (MT Newswires) -- Nikhil Lalwani, Director, President & CEO, on August 12, 2025, sold 56,960 shares in Ani Pharmaceuticals ( ANIP ) for $4,894,573. Following the Form 4 filing with the SEC, Lalwani has control over a total of 411,219 common shares of the company, with 411,219 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1023024/000182262925000010/xslF345X05/wk-form4_1755208123.xml